Geropharm will bring to the Russian market an analogue of the popular weight loss drug Vegovi
In 2025, Geropharm plans to bring to market an analogue of Vegovi - a drug with semaglutide, like the famous...
In 2025, Geropharm plans to bring to market an analogue of Vegovi - a drug with semaglutide, like the famous...
Today, March 25, the Danish manufacturer of weight loss drugs Novo Nordisk announced on the purchase of the German pharmaceutical...
Danish Novo Holdings, which owns weight loss drug manufacturer Novo Nordisk, announced on the purchase of the American pharmaceutical company...
Danish pharmaceutical company Novo Nordisk has become the second European company whose market value has exceeded $500 billion. As reported...
-->-->-->--> Source link
The fact that the Danish Novo Nordisk has a patent for the popular drug for controlling glucose levels “Ozempic” did...
Russian pharmaceutical companies are striving to occupy the niche of the drug for controlling glucose levels Ozempic, the manufacturer of...
The first analogue of the popular drug for controlling glucose levels, Ozempic, has been registered in Russia, which the Danish...
The Russian structure of the Danish pharmaceutical company Novo Nordisk, LLC Novo Nordisk, filed a lawsuit against the Federal Tax...
The Danish insulin manufacturer Novo Nordisk may transfer the supply of drugs to Russia to another company. About it informed...
One of the major European insulin manufacturers Novo Nordisk, following the American BMS and Eli Lilly, may transfer the supply...
The Danish company Novo Nordisk has stopped deliveries of the diabetes drug Ozempic (semaglutide) to Russia. Roszdravnadzor received a notification...